ZUG, SWITZERLAND, 6 December 2024 — Effective monitoring is one of the most critical aspects of clinical trials and one of the most resource-intensive and expensive parts of the process. PSI has introduced PACE™, the latest addition to their cloud-based clinical trial planning platform INTELIA™, to automate, track, and optimize site monitoring activities.
“Effectively managing the increasing volumes of data and the constraints of limited staff, budget, and time is essential and is often a significant contributor to overall trial efficiency,” says Pablo Macgowan, PSI’s Director of Process Improvement.
PACE™ integrates and processes data from PSI’s Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) systems to make data-backed decisions tailored to the sponsor’s specific protocol, including:
- Optimizing monitoring efficiency (number of CRFs reviewed per day on site) while adhering to the projects’ monitoring plans
- Improving the monitor’s allocation process, based on the number of sites, subjects, and volume of data to be monitored to optimize workload across CRAs
- Helping to identify, assess, and reduce critical backlog (site-, monitor-, and project-level)
Based on input from the team and counterpart systems, PACE™ will provide an optimized visit schedule, determining when monitoring visits will be required, and the duration of the visit, ensuring monitors only visit a site when there is enough verifiable data to justify using a full day visit from the budgeted pool.
PACE™ is the latest addition to INTELIA™, PSI’s proprietary cloud-based platform created with the help of a leading global software development company DataArt. The platform brings together a suite of clinical trial planning tools:
- VISIONAL™, AI-powered study modeling
- CLARITY™, study budgeting and forecasting
- CADENCE™, study budget tracking and reporting
INSITE™, investigator grant calculator - And now PACE™, smart monitoring planning
For more information about PACE™ or to schedule an introduction to learn more about PSI’s full-service pivotal trial capabilities, contact us today.
About PSI
PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.
Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com
For Media Inquiries
Paul Mirek
